A Clinical Study of Epilepsy Localization and Prognosis Based on PET and Resting-state fMRI

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-31

Study Completion Date

2024-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

1. By following up the prognosis of surgical patients, the application value of Cortex ID quantitative analysis in the localization of epilepsy foci was studied.
2. By studying the correlation between autonomic nerve function and epilepsy neural network in epilepsy patients, and analyzing the differences between different epilepsy patients, it can provide more information for judging the prognosis of epilepsy patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

An Examination of Cognitive and Sensorimotor Processes in Patients With Epilepsy

NCT00859794

Epilepsy

ENROLLING_BY_INVITATION NA

EEG-fMRI: Towards a Useful Clinical Tool in Epilepsy

NCT02410889

Epilepsy

COMPLETED

Study of Brain Anatomo-functional Substrates Related to the Use of Human Tool by Means of Simultaneous Acquisition of Magnetic Resonance Imaging and Electroencephalogram

NCT05767489

Patients With Frontal and Parietal Lobe Dysfunction

UNKNOWN

Multimodal Functional Neuroimaging in Epilepsy Patients

NCT02132507

Epilepsy

COMPLETED

Cartography of Functional and Epileptic Cerebral Areas by Functional MRI and Electroencephalography in Epileptic Patients Before and After Surgery

NCT03102957

Epilepsy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study included diagnostic trials and case-control studies, which were observational studies with no intervention. First, the demographic and clinical information of epilepsy patients in the Neurology Department of Xijing Hospital were collected, including gender, age, age of onset, course of epilepsy, seizure performance before treatment, seizure frequency before treatment, type and dose of antiepileptic drugs, past history, Family history, etc., as well as imaging, EEG, quality of life, and neuropsychological assessment, etc. were collected; secondly, functional magnetic resonance imaging (fMRI) and 24-hour Holter monitoring were performed on patients who met the inclusion criteria. Positron Emission Computed Tomography (PET) images of patients who have undergone or plan to undergo surgery are analyzed; finally, appropriate statistical methods are used for analysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Epileptic Seizure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

drug-resistant epilepsy

No intervention

Intervention Type OTHER

No intervention

Medication is effective

No intervention

Intervention Type OTHER

No intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Meet the diagnostic criteria for epilepsy,

* No contraindications for fMRI examination.
* The patient had no other heart and lung diseases except epilepsy.
* Patients and their families were aware of this study and signed informed consent.

Exclusion Criteria

* Patients with severe infection, cerebrovascular disease, malignant tumor and other systemic diseases that can affect the nervous system, and those with serious dysfunction of the heart, liver, kidney and other organs.
* Non-epileptic seizures such as syncope and hysteria.
* Pregnant or lactating women. Incomplete clinical data

Eligible Sex

ALL

Accepts Healthy Volunteers

No